Calendar

| Wednesday, January 25, 2023 |
Seminar event

ALA_00210en_us

January 25, 2023, 4:00 PM - 5:00 PM (time zone: UTC)
Status required for completion
Fully attended
Language
English - United States (en_us)
Event booking
Over
Trainer
Aurore Varela, Rachel Bulock
Details

  • This session will discuss major considerations related to EEG investigations: Study design, species selection, adverse event characterization, regulatory considerations, safety margins and translation from animals to humans will be discussed.
  • Seizures may be observed with a wide range of therapeutic classes including antibiotics, gene therapy, oncology, analgesics, cognitive and movement disorder treatments
  • Electroencephalography (EEG) may be applied to all stages of drug development from discovery to late-stage GLP toxicology studies, based on specific considerations and program requirements.
  • Seizure liability, sleep disturbance/drug induced insomnia, and stimulatory/sedative effects are only a few potential justifications for the addition of EEG in rodent or nonrodent neurotoxicology studies.


Go to this Seminar event